|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 10-27 | Irlab Therapeutics Set to Obtain US Patent for Parkinson's Disease Drug Candidate | MT |
| 10-27 | Irlab receives positive patent notice in the US for IRL1117 | FW |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.19% | +11.31% | +23.28% | +23.39% | +31.90% | +64.28% | +155.66% | +468.59% | +1,842.37% | 1,263B | |
| -0.73% | +3.56% | +5.62% | +6.57% | +32.01% | +44.65% | +83.74% | +67.59% | +136.86% | 658B | |
| +1.41% | +3.24% | +13.45% | +17.51% | +29.06% | +35.25% | +106.98% | +156.85% | +422.39% | 521B | |
| -1.33% | +0.61% | +15.39% | +12.05% | +21.54% | +53.72% | +67.50% | +8.56% | +77.84% | 391B | |
| +2.18% | +2.93% | +3.97% | +14.84% | +42.05% | +73.90% | +45.38% | +70.22% | +152.14% | 369B | |
| -1.20% | +3.69% | +13.62% | +6.17% | +20.60% | +32.84% | +56.13% | +72.02% | +90.32% | 307B | |
| -0.34% | +8.30% | +17.27% | +21.05% | +0.94% | +12.59% | +34.34% | +47.66% | +207.60% | 290B | |
| +1.15% | +6.09% | +14.42% | +20.99% | +42.38% | +56.15% | +78.66% | +122.13% | +231.07% | 252B | |
| +3.06% | +9.38% | +15.72% | +31.08% | +39.06% | +42.48% | +112.84% | +160.02% | +130.43% | 212B | |
| -0.04% | +2.30% | +7.12% | -11.86% | -18.08% | -15.49% | -62.45% | -25.36% | +124.00% | 175B | |
| +1.90% | +1.63% | +8.53% | +22.03% | +22.57% | +23.81% | +0.03% | -30.06% | -1.77% | 174B | |
| +3.50% | +6.67% | +10.29% | +17.14% | +23.28% | +31.33% | +51.32% | +201.45% | +617.62% | 142B | |
| +1.78% | +1.63% | +1.66% | -4.33% | +15.83% | +35.62% | +21.84% | +6.48% | +22.99% | 128B | |
| +1.40% | -0.62% | +10.65% | +16.16% | +21.25% | +22.58% | +116.41% | +377.98% | +669.38% | 116B | |
| -0.18% | +6.73% | +12.41% | +6.85% | -3.77% | -8.44% | -8.72% | -11.17% | +10.79% | 107B | |
| -0.78% | -3.71% | +3.62% | -3.43% | +1.07% | +4.95% | +32.09% | -5.71% | -8.17% | 99.63B | |
| +13.33% | +15.26% | +26.28% | +21.67% | +20.21% | +42.36% | +17.27% | +45.18% | +167.75% | 93.11B | |
| -0.47% | +10.80% | +17.35% | +304.45% | +651.85% | +716.35% | +190.97% | -34.24% | - | 88.52B | |
| -0.56% | +4.87% | +10.01% | +5.72% | +22.84% | +34.77% | +4.98% | -28.25% | +63.38% | 73.45B | |
| Average | +1.50% | +5.36% | +12.14% | +27.79% | +53.50% | +68.62% | +58.16% | +87.89% | +275.39% | 287.26B | |
| Weighted average by Cap. | +1.36% | +6.10% | +13.88% | +19.84% | +35.81% | +54.34% | +83.39% | +166.46% | +578.61% |
- Stock Market
- Stocks
- IRLAB A Stock
- Stock
- Sector IRLAB Therapeutics AB
Select your edition
All financial news and data tailored to specific country editions
